Skip to main content
SpringerLink
Log in

Where Are We in the Medical Treatment of Nasal Polyps

  • Chapter
  • First Online:
Nasal Polyposis

  • 1398 Accesses

Abstract

Nasal polyposis (NP) is associated with a number of medical conditions and may be considered to be the end-point of a number of different pathological processes. For many patients, NP should be regarded primarily as a medically managed condition in which surgery often plays a role. It could be argued that the surgery facilitates the instillation of nasal medication. A range of medical treatments are available though the mainstay remains corticosteroids in various forms. However, there are a number of other approaches both new and old which may be considered. Randomised placebo-controlled trials are available for a relatively small number of preparations and more need to be conducted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aukema AAC, Mulder PGH, Fokkens WJ (2005) Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol 115:1017–1023

    Article  PubMed  CAS  Google Scholar 

  2. Benitez P, Alobid I, De Haro J, Berenguer J, Bernal-Sprekelsen M, Pujols L et al (2006) A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 116(5):770–775

    Article  PubMed  CAS  Google Scholar 

  3. Bielory L, Blaiss M, Fineman SM, Ledford DK, Lieberman P, Simons FE et al (2006) Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 96(4):514–525

    Article  PubMed  CAS  Google Scholar 

  4. Cave A, Arlett P, Lee E (1999) Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 83(3):153–179

    Article  PubMed  CAS  Google Scholar 

  5. Damm M, Jungehulsing M, Eckel HE, Schmidt M, Theissen P (1999) Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 120(4):517–523

    Article  PubMed  CAS  Google Scholar 

  6. Desrosiers MY, Salas-Prato M (2001) Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 125(3):265–269

    Article  PubMed  CAS  Google Scholar 

  7. Deuschl H, Drettner B (1977) Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 15(1):17–23

    PubMed  CAS  Google Scholar 

  8. Dingsor G, Kramer J, Olsholt R, Soderstrom T (1985) Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study. Rhinology 23(1):49–58

    PubMed  CAS  Google Scholar 

  9. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J et al (2006) Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 118(5):1149–1156

    Article  PubMed  CAS  Google Scholar 

  10. Elbez M, De Pressigny M, Halimi P, Aidan D, Bonfils P, Trotoux J (1993) Does the use of nasal vasoconstrictor agents change tomodensitometric images of nasosinusal polyposis? Ann Otolaryngol Chir Cervicofac 110(5): 277–280

    PubMed  CAS  Google Scholar 

  11. Fokkens W, Lund V, Mullol J et al (2007) European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl 20:1–136

    PubMed  Google Scholar 

  12. Graf P, Enerdal J, Hallen H (1999) Ten days’ use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg 125(10):1128–1132

    PubMed  CAS  Google Scholar 

  13. Goossens H, Ferech M, Vander Stichele R, Elseviers M (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365(9459):579–587

    Google Scholar 

  14. Hadfield PJ, Rowe-Jones JM, Mackay IS (2000) A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology 38(2):63–65

    PubMed  CAS  Google Scholar 

  15. Hartwig S, Linden M, Laurent C, Vargo AK, Lindqvist N (1988) Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial). J Laryngol Otol 102(2):148–151

    Article  PubMed  CAS  Google Scholar 

  16. Hashiba M, Baba S (1996) Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 525:73–78

    PubMed  CAS  Google Scholar 

  17. Haye R, Aanesen JP, Burtin B, Donnelly F, Duby C (1998) The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 112(11):1042–1046

    Article  PubMed  CAS  Google Scholar 

  18. Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D et al (2006) Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 118(1):128–133

    Article  PubMed  CAS  Google Scholar 

  19. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E (1998) A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol 23(1):69–73

    Article  PubMed  CAS  Google Scholar 

  20. Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G (1997) Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 78(3):270–276

    Article  PubMed  CAS  Google Scholar 

  21. Holopainen E, Grahne B, Malmberg H, Makinien J, Lindqvist N (1982) Budesonide in the treatment of nasal polyposis. Eur J Respir Dis Suppl 122:221–228

    PubMed  CAS  Google Scholar 

  22. Johansson L, Oberg D, Melen I, Bende M (2006) Do topical nasal decongestants affect polyps? Acta Otolaryngologica 126(3):288–290

    Article  Google Scholar 

  23. Karlsson G, Rundcrantz H (1982) A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 20(3):144–148

    PubMed  CAS  Google Scholar 

  24. Keith P, Nieminen J, Hollingworth K, Dolovich J (2000) Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 30(10):1460–1468

    Article  PubMed  CAS  Google Scholar 

  25. Kennedy DW, Kuhn F, Hamilos D, Zinreich J, Butler D, Warsi G (2005) Treatment of chronic rhinosinusitis with high-dose terbinafine. A double blind, placebo-controlled study. Laryngoscope 115:1793–1799

    Article  PubMed  CAS  Google Scholar 

  26. Kieff DA, Busaba NY (2005) Efficacy of montelukast in the treatment of nasal polyposis. Ann Otol Rhinol Laryngol 114(12 I):941–945

    PubMed  Google Scholar 

  27. Kroflic B, Coer A, Baudoin T, Kalogjera L (2006) Topical furosemide versus oral steroid in preoperative management of nasal polyposis. Eur Arch Otorhinolaryngol 263(8): 767–771

    Article  PubMed  Google Scholar 

  28. Leung DY, Bloom JW (2003) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 111(1):3–22; quiz 3

    Article  PubMed  CAS  Google Scholar 

  29. Lildholdt T, Rundcrantz H, Lindqvist N (1995) Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 20(1):26–30

    Article  PubMed  CAS  Google Scholar 

  30. Lildholdt T, Fogstrup J, Gammelgaard N, Kortholm B, Ulsoe C (1988) Surgical versus medical treatment of nasal polyps. Acta Otolaryngol 105(1–2):140–143

    Article  PubMed  CAS  Google Scholar 

  31. Lund VJ, Flood J, Sykes AP, Richards DH (1998) Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 124(5):513–518

    PubMed  CAS  Google Scholar 

  32. Lund VJ, Preziosi P, Hercberg S, Hamoir M, Dubreuil C, Pessey JJ et al (2006) Yearly incidence of rhinitis, nasal bleeding, and other nasal symptoms in mature women. Rhinology 44(1):26–31

    PubMed  Google Scholar 

  33. Mostafa BE, Abdel HH, Mohammed HE, Yamani M (2005) Role of leukotriene inhibitors in the postoperative management of nasal polyps. ORL J Otorhinolaryngol Relat Spec 67(3):148

    Article  PubMed  CAS  Google Scholar 

  34. Mullol J, Xaubet A, Gaya A, Roca-Ferrer J, Lopez E, Fernandez JC et al (1995) Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 25(7):607–615

    Article  CAS  Google Scholar 

  35. Mullol J, Xaubet A, Lopez E, Roca-Ferrer J, Picado C (1995) Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 50(3):270–274

    Article  PubMed  CAS  Google Scholar 

  36. Mullol J, Lopez E, Roca-Ferrer J, Xaubet A, Pujols L, Fernandez-Morata JC et al (1997) Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clin Exp Allergy 27(12):1432–1441

    Article  CAS  Google Scholar 

  37. Myers JD, Higham MA, Shakur BH, Wickremasinghe M, Ind PW (1997) Attenuation of propranolol-induced bronchoconstriction by frusemide. Thorax 52(10):861–865

    Article  PubMed  CAS  Google Scholar 

  38. Mygind N, Pedersen CB, Prytz S, Sorensen H (1975) Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 5(2):159–164

    Article  PubMed  CAS  Google Scholar 

  39. Parikh AA, Scadding GK (2005) Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 115(8):1385–1390

    Article  PubMed  CAS  Google Scholar 

  40. Passali D, Bernstein JM, Passali FM, Damiani V, Passali GC, Bellussi L (2003) Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg 129(6):656–659

    Article  PubMed  Google Scholar 

  41. Penttila M, Poulsen P, Hollingworth K, Holmstrom M (2000) Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy 30(1):94–102

    Article  PubMed  CAS  Google Scholar 

  42. Ponikau JU, Sherris DA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115(1):125–131

    Article  PubMed  CAS  Google Scholar 

  43. Ragab S, Parikh A, Darby YC, Scadding GK (2001) An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 31(9):1385–1391

    Article  PubMed  CAS  Google Scholar 

  44. Ragab SM, Lund VJ, Scadding GK (2004) Evaluation of medical and surgical treatment of chronic rhinosinusitis: a prospective randomised, controlled trial. Laryngoscope 114:923–930

    Article  PubMed  Google Scholar 

  45. Ragab S, Scadding GK, Lund VJ, Saleh H (2006) The treatment of chronic rhinosinusitis and its effect on asthma. Eur Respir J 28:68–74

    Article  PubMed  CAS  Google Scholar 

  46. Roca-Ferrer J, Mullol J, Lopez E, Xaubet A, Pujols L, Fernandez JC et al (1997) Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. Eur Respir J 10(7):1489–1495

    Article  PubMed  CAS  Google Scholar 

  47. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS (2005) Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 43(1):2–10

    PubMed  Google Scholar 

  48. Salib RJ, Howarth PH (2003) Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 26(12):863–893

    Article  PubMed  CAS  Google Scholar 

  49. Shekelle PG, Woolf SH, Eccles M, Grimshaw J (1999) Clinical guidelines: developing guidelines. BMJ 318(7183): 593–596

    Article  PubMed  CAS  Google Scholar 

  50. Small CB, Hernandez J, Reyes A, Schenkel E, Damiano A, Stryszak P et al (2005) Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 116(6):1275–1281

    Article  PubMed  CAS  Google Scholar 

  51. Stjarne P, Blomgren K, Caye-Thomasen P, Salo S, Soderstrom T (2006) The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: A randomized, double-blind, placebo-controlled study. Acta Otolaryngologica 126(6):606–612

    Article  Google Scholar 

  52. Stjarne P, Mosges R, Jorissen M, Passali D, Bellussi L, Staudinger H et al (2006) A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 132(2): 179–185

    Article  PubMed  Google Scholar 

  53. Tos M, Svendstrup F, Arndal H, Orntoft S, Jakobsen J, Borum P et al (1998) Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. Am J Rhinol 12(3):183–189

    Article  PubMed  CAS  Google Scholar 

  54. van Camp C, Clement PA (1994) Results of oral steroid treatment in nasal polyposis. Rhinology 32(1):5–9

    PubMed  Google Scholar 

  55. Vendelo Johansen L, Illum P, Kristensen S, Winther L, Vang Petersen S, Synnerstad B (1993) The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 18(6):524–527

    Article  PubMed  CAS  Google Scholar 

  56. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A (2006) A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116(2):189–193

    Article  PubMed  CAS  Google Scholar 

  57. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113(6): 1122–1128

    Article  PubMed  CAS  Google Scholar 

  58. Xaubet A, Mullol J, Lopez E, Roca-Ferrer J, Rozman M, Carrion T et al (1994) Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 24(4):307–317

    Article  PubMed  CAS  Google Scholar 

  59. Xaubet A, Mullol J, Roca-Ferrer J, Pujols L, Fuentes M, Perez M et al (2001) Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. Respir Med 95(5):408–414

    Article  PubMed  CAS  Google Scholar 

  60. Zheng C, Wang Z, Lacroix JS (2000) Effect of intranasal treatment with capsaicin on the recurrence of polyps after polypectomy and ethmoidectomy. Acta Otolaryngol 120(1):62–66

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal National Throat, Nose and Ear Hospital, University College London, 330 Grays Inn Road, London, WC1X 8DA, UK

    Valerie J. Lund

Authors
  1. Valerie J. Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valerie J. Lund .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Dept. of Otorhinolaryngology, Hacettepe University, Ankara, 06100, Turkey

    T. Metin Önerci

  2. School of Medicine, Dept. Otolaryngology, University of Pittsburgh, Locust Street 1400, Pittsburgh, 15219, USA

    Berrylin J. Ferguson

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lund, V.J. (2010). Where Are We in the Medical Treatment of Nasal Polyps. In: Önerci, T., Ferguson, B. (eds) Nasal Polyposis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11412-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11412-0_27

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11411-3

  • Online ISBN: 978-3-642-11412-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation